Maravai LifeSciences Holdings has a quick ratio of 4.96. It generally indicates good short-term financial strength.
The historical rank and industry rank for Maravai LifeSciences Holdings's Quick Ratio or its related term are showing as below:
MEX:MRVI'
s Quick Ratio Range Over the Past 10 Years
Min: 0.42 Med: 5.69 Max: 10.47
Current: 4.96
During the past 8 years, Maravai LifeSciences Holdings's highest Quick Ratio was 10.47. The lowest was 0.42. And the median was 5.69.
MEX:MRVI's Quick Ratio is ranked better than 59.7% of 1412
companies
in the Biotechnology industry
Industry Median: 3.6
vs MEX:MRVI: 4.96
Maravai LifeSciences Holdings (MEX:MRVI) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Maravai LifeSciences Holdings Quick Ratio Related Terms
Maravai LifeSciences Holdings Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:MRVI vs LBRX, SLDB, JANX: Quick Ratio Comparison
For the Biotechnology subindustry, Maravai LifeSciences Holdings's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maravai LifeSciences Holdings Quick Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Maravai LifeSciences Holdings's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Maravai LifeSciences Holdings's Quick Ratio falls into.
Maravai LifeSciences Holdings Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maravai LifeSciences Holdings (MEX:MRVI) has a Quick Ratio of 4.96 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Maravai LifeSciences Holdings and its competitors. This is 13% below median its historical median of 5.69. Over the past decade, Maravai LifeSciences Holdings' Quick Ratio has ranged from 0.42 to 10.47. According to the industry distribution chart, Maravai LifeSciences Holdings ranks #569 out of 1412 companies in the Biotechnology industry, placing it in the top 40.3%.
Is Maravai LifeSciences Holdings' Quick Ratio too high?
Maravai LifeSciences Holdings' current Quick Ratio of 4.96 is 13% below median its 10-year median of 5.69. Over the past 10 years, this metric has ranged from a low of 0.42 to a high of 10.47. The Biotechnology industry median Quick Ratio is 3.60. Maravai LifeSciences Holdings' value of 4.96 is 37.8% above this industry median. Based on the distribution chart, Maravai LifeSciences Holdings ranks #569 out of 1412 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Maravai LifeSciences Holdings has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Maravai LifeSciences Holdings' Quick Ratio compare to LBRX and SLDB?
According to the Biotechnology industry distribution chart, Maravai LifeSciences Holdings ranks #569 out of 1412 companies for Quick Ratio. This puts Maravai LifeSciences Holdings in the upper half of its industry. The industry median Quick Ratio is 3.60. Maravai LifeSciences Holdings' value of 4.96 is 37.8% above this benchmark. Historically, Maravai LifeSciences Holdings' own Quick Ratio has ranged from 0.42 to 10.47 over the past decade. While the company's 10-year median is 5.69 vs. the industry median of 3.60, Maravai LifeSciences Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.60, based on 1,412 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Maravai LifeSciences Holdings's current Quick Ratio of 4.96 is 37.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Maravai LifeSciences Holdings and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maravai LifeSciences Holdings's current Quick Ratio is 4.96, which is 13% below median its own 10-year median of 5.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maravai LifeSciences Holdings stock overvalued right now?
Maravai LifeSciences Holdings (MEX:MRVI) has a current Quick Ratio of 4.96. The stock's GF Value™ is MXN52.37, compared to a current price of MXN85.00 — trading 62.3% above its estimated fair value. The current Quick Ratio is 4.96, which is 13% below median its 10-year median of 5.69 and 37.8% above the Biotechnology industry median of 3.60. Maravai LifeSciences Holdings' overall GF Score™ is 62/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Maravai LifeSciences Holdings (MEX:MRVI), the current Quick Ratio is 4.96 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maravai LifeSciences Holdings (MEX:MRVI) Overvalued in 2026?
Based on GuruFocus' analysis, Maravai LifeSciences Holdings stock appears to be overvalued.
The current stock price of MXN85.00 is trading 62.3% above its estimated GF Value™ of MXN52.37.
Key valuation signals for MEX:MRVI:
Quick Ratio: 4.96 (13% below median its 10-year median of 5.69)
GF Value™: MXN52.37 vs. price of MXN85.00 (62.3% above fair value)
Industry Position: 37.8% above the Biotechnology median (#569 of 1412)
No single metric tells the full story. See the MEX:MRVI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Maravai LifeSciences Holdings Business Description
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
62GF Score
Get the complete analysis for MEX:MRVI
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:MRVI has been successfully added to your 
